CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,222
- in 5 filings, $701K under 10b5-1 plans
Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-29 | Marriott Tina President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,000 | 464,000 | ||
| 2024-08-29 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +5,000 | $2.48 | $12K | 757,656 |
| 2024-08-29 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 287,500 | ||
| 2024-08-28 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +5,000 | $2.48 | $12K | 752,656 |
| 2024-08-28 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 292,500 | ||
| 2024-08-27 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +5,000 | $2.48 | $12K | 747,656 |
| 2024-08-27 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 297,500 | ||
| 2024-08-26 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +5,000 | $2.48 | $12K | 742,656 |
| 2024-08-26 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 302,500 | ||
| 2024-08-23 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +5,000 | $2.48 | $12K | 737,656 |
| 2024-08-23 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 307,500 | ||
| 2024-08-20 | Borgeson Blake Director | Sale 10b5-1 | −11,447 | $7.12 | $82K | 7,132,769 |
| 2024-08-15 | Marriott Tina President and COO | Shares withheld for taxes | −14,319 | $6.69 | $96K | 521,138 |
| 2024-08-15 | Mauro David J Chief Medical Officer | Shares withheld for taxes | −14,146 | $6.69 | $95K | 229,616 |
| 2024-08-15 | Gibson Christopher Chief Executive Officer | Shares withheld for taxes | −26,082 | $6.69 | $174K | 732,656 |
| 2024-08-15 | Secora Michael Chief Financial Officer | Shares withheld for taxes | −11,962 | $6.69 | $80K | 1,353,381 |
| 2024-08-14 | Secora Michael Chief Financial Officer | Exercise or conversion 10b5-1 | +39,375 | $2.22 | $87K | 1,380,343 |
| 2024-08-14 | Secora Michael Chief Financial Officer | Sale 10b5-1 | −15,000 | $6.35 | $95K | 1,365,343 |
| 2024-08-14 | Secora Michael Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −39,375 | 573,885 | ||
| 2024-08-13 | Secora Michael Chief Financial Officer | Exercise or conversion 10b5-1 | +39,375 | $2.22 | $87K | 1,355,968 |
Page 16 of 41 · 805 trades